Hyderabad-based pharma company Bharat Biotech to conduct phase 3 clinical trial tests in October. Uttar Pradesh Health Minister Jai Pratap Singh said around 3,000 people to be tested under the phase 3 trial of the vaccine candidate. Bharat Biotech is working with the Indian Council of Medical Research (ICMR) to develop a vaccine candidate – Covaxin. The pharma company recently signed an agreement with the Washington University School of Medicine for an intranasal single-dose vaccine. Watch the full video for more details.